Complementarity determining region-grafted antibody against...

Details Complementarity determining region-grafted antibody against... Complementarity determining region-grafted antibody against...

C - Chemistry, Metallurgy

07

K

C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) C07K 16/18 (2006.01) C12N 5/10 (2006.01) C12N 15/13 (2006.01) C12P 21/08 (2006.01)

Patent

CA 2386197

A human type CDR transplantation antibody against ganglioside GD3 (hereinafter referred to as GD3); derivatives of the antiGD3 antibody with cytokines; and therapeutic and diagnostic utilization of the above-described antibody and derivatives.

L'invention concerne un anticorps de transplantation CDR de type humain agissant contre le ganglioside GD3 (ci-après dénommé GD3); des dérivés dudit anticorps anti-GD3 comportant des cytokines; et l'utilisation de l'anticorps et des dérivés à des fins thérapeutiques ou diagnostiques.

Affiliated with

Also associated with

Rating

Complementarity determining region-grafted antibody against... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Complementarity determining region-grafted antibody against..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Complementarity determining region-grafted antibody against... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2017836